The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Fecal Microbiota Transplantation Market Research Report 2025
Synopsis
Fecal microbiota transplantation refers to the practice of transplanting stool from a healthy donor into the gastrointestinal tract of the patient. This procedure restores the balance of bacteria in the digestive tract by replenishing the population of ‘good’ bacteria that is either suppressed by the overpopulation of ‘bad’ bacteria or has been killed. Prepared fecal microbiota transplantation is a thoroughly screened process. It is carried out in the lower gastrointestinal tract through colonoscopy or enema and in the upper gastrointestinal tract through the nasoduodenal or nasogastric tube. Currently, fecal microbiota transplantation is being studied for the treatment of Clostridium difficile infection but can be used for the treatment of gut dysbiosis after heavy treatment such as chemotherapy. Patietns with recurrent clostridium infections treated with fecal microbiota transplantation have shown high rates of success. A study has found that 90% recurrent C. difficile cases treated with fecal microbiota transplantation achieve clinical resolution. Thus, this has elevated fecal microbiota transplantation as an emerging treatment for a wide range of disorders, including fibromyalgia, Parkinson’s disease, myoclonus dystopia, chronic fatigue syndrome, multiple sclerosis, insulin resistance, obesity, metabolic syndrome, and autism.
Highlights
The global Fecal Microbiota Transplantation market is projected to reach US$ million by 2028 from an estimated US$ million in 2022, at a CAGR of % during 2023 and 2028.
North American market for Fecal Microbiota Transplantation is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
Asia-Pacific market for Fecal Microbiota Transplantation is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2022 through 2028.
The global market for Fecal Microbiota Transplantation in Clostridium Difficile Infections is estimated to increase from $ million in 2022 to $ million by 2028, at a CAGR of % during the forecast period of 2022 through 2028.
The major global companies of Fecal Microbiota Transplantation include Rebiotix, Finch Therapeutics, Seres Therapeutics and Crestovo, etc. In 2021, the world's top three vendors accounted for approximately % of the revenue.
Considering the economic change due to COVID-19, Phase-I, which accounted for % of the global market of Fecal Microbiota Transplantation in 2021, is expected to reach US$ million by 2028, growing at a revised CAGR of % from 2022 to 2028.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Fecal Microbiota Transplantation, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Fecal Microbiota Transplantation.
The Fecal Microbiota Transplantation market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2021 as the base year, with history and forecast data for the period from 2017 to 2028. This report segments the global Fecal Microbiota Transplantation market comprehensively. Regional market sizes, concerning products by types, by application, and by players, are also provided. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Fecal Microbiota Transplantation companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, product type, application, and regions.
Key Companies & Market Share Insights
In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue by companies for the period 2017-2022. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:
Rebiotix
Finch Therapeutics
Seres Therapeutics
Crestovo
Product Type Insights
Global markets are presented by Fecal Microbiota Transplantation type, along with growth forecasts through 2028. Estimates on revenue are based on the price in the supply chain at which the Fecal Microbiota Transplantation are procured by the companies.
This report has studied every segment and provided the market size using historical data. They have also talked about the growth opportunities that the segment may pose in the future. This study bestows revenue data by type, and during the historical period (2017-2022) and forecast period (2023-2028).
Fecal Microbiota Transplantation segment by Type
Phase-I
Phase-2
Phase-3
Phase-4
Application Insights
This report has provided the market size (revenue data) by application, during the historical period (2017-2022) and forecast period (2023-2028).
This report also outlines the market trends of each segment and consumer behaviors impacting the Fecal Microbiota Transplantation market and what implications these may have on the industry's future. This report can help to understand the relevant market and consumer trends that are driving the Fecal Microbiota Transplantation market.
Fecal Microbiota Transplantation Segment by Application
Clostridium Difficile Infections
Parkinson Disease
Obesity
Diabetes Mellitus
Autism
Others
Regional Outlook
This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the revenue data of each region and country for the period 2017-2028.
The market has been segmented into various major geographies, including North America, Europe, Asia-Pacific, South America, Middle East & Africa. Detailed analysis of major countries such as the USA, Germany, the U.K., Italy, France, China, Japan, South Korea, Southeast Asia, and India will be covered within the regional segment. For market estimates, data are going to be provided for 2021 because of the base year, with estimates for 2022 and forecast revenue for 2028.
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
COVID-19 and Russia-Ukraine War Influence Analysis
The readers in the section will understand how the Fecal Microbiota Transplantation market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.
Reasons to Buy This Report
This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Fecal Microbiota Transplantation market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
This report will help stakeholders to understand the global industry status and trends of Fecal Microbiota Transplantation and provides them with information on key market drivers, restraints, challenges, and opportunities.
This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
This report stays updated with novel technology integration, features, and the latest developments in the market
This report helps stakeholders to understand the COVID-19 and Russia-Ukraine War Influence on the Fecal Microbiota Transplantation industry.
This report helps stakeholders to gain insights into which regions to target globally
This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Fecal Microbiota Transplantation.
This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Fecal Microbiota Transplantation companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Fecal microbiota transplantation refers to the practice of transplanting stool from a healthy donor into the gastrointestinal tract of the patient. This procedure restores the balance of bacteria in the digestive tract by replenishing the population of ‘good’ bacteria that is either suppressed by the overpopulation of ‘bad’ bacteria or has been killed. Prepared fecal microbiota transplantation is a thoroughly screened process. It is carried out in the lower gastrointestinal tract through colonoscopy or enema and in the upper gastrointestinal tract through the nasoduodenal or nasogastric tube. Currently, fecal microbiota transplantation is being studied for the treatment of Clostridium difficile infection but can be used for the treatment of gut dysbiosis after heavy treatment such as chemotherapy. Patietns with recurrent clostridium infections treated with fecal microbiota transplantation have shown high rates of success. A study has found that 90% recurrent C. difficile cases treated with fecal microbiota transplantation achieve clinical resolution. Thus, this has elevated fecal microbiota transplantation as an emerging treatment for a wide range of disorders, including fibromyalgia, Parkinson’s disease, myoclonus dystopia, chronic fatigue syndrome, multiple sclerosis, insulin resistance, obesity, metabolic syndrome, and autism.
Highlights
The global Fecal Microbiota Transplantation market is projected to reach US$ million by 2028 from an estimated US$ million in 2022, at a CAGR of % during 2023 and 2028.
North American market for Fecal Microbiota Transplantation is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
Asia-Pacific market for Fecal Microbiota Transplantation is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2022 through 2028.
The global market for Fecal Microbiota Transplantation in Clostridium Difficile Infections is estimated to increase from $ million in 2022 to $ million by 2028, at a CAGR of % during the forecast period of 2022 through 2028.
The major global companies of Fecal Microbiota Transplantation include Rebiotix, Finch Therapeutics, Seres Therapeutics and Crestovo, etc. In 2021, the world's top three vendors accounted for approximately % of the revenue.
Considering the economic change due to COVID-19, Phase-I, which accounted for % of the global market of Fecal Microbiota Transplantation in 2021, is expected to reach US$ million by 2028, growing at a revised CAGR of % from 2022 to 2028.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Fecal Microbiota Transplantation, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Fecal Microbiota Transplantation.
The Fecal Microbiota Transplantation market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2021 as the base year, with history and forecast data for the period from 2017 to 2028. This report segments the global Fecal Microbiota Transplantation market comprehensively. Regional market sizes, concerning products by types, by application, and by players, are also provided. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Fecal Microbiota Transplantation companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, product type, application, and regions.
Key Companies & Market Share Insights
In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue by companies for the period 2017-2022. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:
Rebiotix
Finch Therapeutics
Seres Therapeutics
Crestovo
Product Type Insights
Global markets are presented by Fecal Microbiota Transplantation type, along with growth forecasts through 2028. Estimates on revenue are based on the price in the supply chain at which the Fecal Microbiota Transplantation are procured by the companies.
This report has studied every segment and provided the market size using historical data. They have also talked about the growth opportunities that the segment may pose in the future. This study bestows revenue data by type, and during the historical period (2017-2022) and forecast period (2023-2028).
Fecal Microbiota Transplantation segment by Type
Phase-I
Phase-2
Phase-3
Phase-4
Application Insights
This report has provided the market size (revenue data) by application, during the historical period (2017-2022) and forecast period (2023-2028).
This report also outlines the market trends of each segment and consumer behaviors impacting the Fecal Microbiota Transplantation market and what implications these may have on the industry's future. This report can help to understand the relevant market and consumer trends that are driving the Fecal Microbiota Transplantation market.
Fecal Microbiota Transplantation Segment by Application
Clostridium Difficile Infections
Parkinson Disease
Obesity
Diabetes Mellitus
Autism
Others
Regional Outlook
This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the revenue data of each region and country for the period 2017-2028.
The market has been segmented into various major geographies, including North America, Europe, Asia-Pacific, South America, Middle East & Africa. Detailed analysis of major countries such as the USA, Germany, the U.K., Italy, France, China, Japan, South Korea, Southeast Asia, and India will be covered within the regional segment. For market estimates, data are going to be provided for 2021 because of the base year, with estimates for 2022 and forecast revenue for 2028.
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
COVID-19 and Russia-Ukraine War Influence Analysis
The readers in the section will understand how the Fecal Microbiota Transplantation market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.
Reasons to Buy This Report
This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Fecal Microbiota Transplantation market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
This report will help stakeholders to understand the global industry status and trends of Fecal Microbiota Transplantation and provides them with information on key market drivers, restraints, challenges, and opportunities.
This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
This report stays updated with novel technology integration, features, and the latest developments in the market
This report helps stakeholders to understand the COVID-19 and Russia-Ukraine War Influence on the Fecal Microbiota Transplantation industry.
This report helps stakeholders to gain insights into which regions to target globally
This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Fecal Microbiota Transplantation.
This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Fecal Microbiota Transplantation companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Fecal Microbiota Transplantation Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
1.2.2 Phase-I
1.2.3 Phase-2
1.2.4 Phase-3
1.2.5 Phase-4
1.3 Market by Application
1.3.1 Global Fecal Microbiota Transplantation Market Share by Application: 2017 VS 2021 VS 2028
1.3.2 Clostridium Difficile Infections
1.3.3 Parkinson Disease
1.3.4 Obesity
1.3.5 Diabetes Mellitus
1.3.6 Autism
1.3.7 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Fecal Microbiota Transplantation Market Perspective (2017-2028)
2.2 Fecal Microbiota Transplantation Growth Trends by Region
2.2.1 Fecal Microbiota Transplantation Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Fecal Microbiota Transplantation Historic Market Size by Region (2017-2022)
2.2.3 Fecal Microbiota Transplantation Forecasted Market Size by Region (2023-2028)
2.3 Fecal Microbiota Transplantation Market Dynamics
2.3.1 Fecal Microbiota Transplantation Industry Trends
2.3.2 Fecal Microbiota Transplantation Market Drivers
2.3.3 Fecal Microbiota Transplantation Market Challenges
2.3.4 Fecal Microbiota Transplantation Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Fecal Microbiota Transplantation Players by Revenue
3.1.1 Global Top Fecal Microbiota Transplantation Players by Revenue (2017-2022)
3.1.2 Global Fecal Microbiota Transplantation Revenue Market Share by Players (2017-2022)
3.2 Global Fecal Microbiota Transplantation Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Fecal Microbiota Transplantation Revenue
3.4 Global Fecal Microbiota Transplantation Market Concentration Ratio
3.4.1 Global Fecal Microbiota Transplantation Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Fecal Microbiota Transplantation Revenue in 2021
3.5 Fecal Microbiota Transplantation Key Players Head office and Area Served
3.6 Key Players Fecal Microbiota Transplantation Product Solution and Service
3.7 Date of Enter into Fecal Microbiota Transplantation Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Fecal Microbiota Transplantation Breakdown Data by Type
4.1 Global Fecal Microbiota Transplantation Historic Market Size by Type (2017-2022)
4.2 Global Fecal Microbiota Transplantation Forecasted Market Size by Type (2023-2028)
5 Fecal Microbiota Transplantation Breakdown Data by Application
5.1 Global Fecal Microbiota Transplantation Historic Market Size by Application (2017-2022)
5.2 Global Fecal Microbiota Transplantation Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Fecal Microbiota Transplantation Market Size (2017-2028)
6.2 North America Fecal Microbiota Transplantation Market Size by Country (2017-2022)
6.3 North America Fecal Microbiota Transplantation Market Size by Country (2023-2028)
6.4 United States
6.5 Canada
7 Europe
7.1 Europe Fecal Microbiota Transplantation Market Size (2017-2028)
7.2 Europe Fecal Microbiota Transplantation Market Size by Country (2017-2022)
7.3 Europe Fecal Microbiota Transplantation Market Size by Country (2023-2028)
7.4 Germany
7.5 France
7.6 U.K.
7.7 Italy
7.8 Russia
7.9 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Fecal Microbiota Transplantation Market Size (2017-2028)
8.2 Asia-Pacific Fecal Microbiota Transplantation Market Size by Country (2017-2022)
8.3 Asia-Pacific Fecal Microbiota Transplantation Market Size by Country (2023-2028)
8.4 China
8.5 Japan
8.6 South Korea
8.7 Southeast Asia
8.8 India
8.9 Australia
9 Latin America
9.1 Latin America Fecal Microbiota Transplantation Market Size (2017-2028)
9.2 Latin America Fecal Microbiota Transplantation Market Size by Country (2017-2022)
9.3 Latin America Fecal Microbiota Transplantation Market Size by Country (2023-2028)
9.4 Mexico
9.5 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Fecal Microbiota Transplantation Market Size (2017-2028)
10.2 Middle East & Africa Fecal Microbiota Transplantation Market Size by Country (2017-2022)
10.3 Middle East & Africa Fecal Microbiota Transplantation Market Size by Country (2023-2028)
10.4 Turkey
10.5 Saudi Arabia
10.6 UAE
11 Key Players Profiles
11.1 Rebiotix
11.1.1 Rebiotix Company Detail
11.1.2 Rebiotix Business Overview
11.1.3 Rebiotix Fecal Microbiota Transplantation Introduction
11.1.4 Rebiotix Revenue in Fecal Microbiota Transplantation Business (2017-2022)
11.1.5 Rebiotix Recent Development
11.2 Finch Therapeutics
11.2.1 Finch Therapeutics Company Detail
11.2.2 Finch Therapeutics Business Overview
11.2.3 Finch Therapeutics Fecal Microbiota Transplantation Introduction
11.2.4 Finch Therapeutics Revenue in Fecal Microbiota Transplantation Business (2017-2022)
11.2.5 Finch Therapeutics Recent Development
11.3 Seres Therapeutics
11.3.1 Seres Therapeutics Company Detail
11.3.2 Seres Therapeutics Business Overview
11.3.3 Seres Therapeutics Fecal Microbiota Transplantation Introduction
11.3.4 Seres Therapeutics Revenue in Fecal Microbiota Transplantation Business (2017-2022)
11.3.5 Seres Therapeutics Recent Development
11.4 Crestovo
11.4.1 Crestovo Company Detail
11.4.2 Crestovo Business Overview
11.4.3 Crestovo Fecal Microbiota Transplantation Introduction
11.4.4 Crestovo Revenue in Fecal Microbiota Transplantation Business (2017-2022)
11.4.5 Crestovo Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of TablesList of Tables
Table 1. Global Fecal Microbiota Transplantation Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028
Table 2. Key Players of Phase-I
Table 3. Key Players of Phase-2
Table 4. Key Players of Phase-3
Table 5. Key Players of Phase-4
Table 6. Global Fecal Microbiota Transplantation Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028
Table 7. Global Fecal Microbiota Transplantation Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
Table 8. Global Fecal Microbiota Transplantation Market Size by Region (2017-2022) & (US$ Million)
Table 9. Global Fecal Microbiota Transplantation Market Share by Region (2017-2022)
Table 10. Global Fecal Microbiota Transplantation Forecasted Market Size by Region (2023-2028) & (US$ Million)
Table 11. Global Fecal Microbiota Transplantation Market Share by Region (2023-2028)
Table 12. Fecal Microbiota Transplantation Market Trends
Table 13. Fecal Microbiota Transplantation Market Drivers
Table 14. Fecal Microbiota Transplantation Market Challenges
Table 15. Fecal Microbiota Transplantation Market Restraints
Table 16. Global Fecal Microbiota Transplantation Revenue by Players (2017-2022) & (US$ Million)
Table 17. Global Fecal Microbiota Transplantation Market Share by Players (2017-2022)
Table 18. Global Top Fecal Microbiota Transplantation Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Fecal Microbiota Transplantation as of 2021)
Table 19. Ranking of Global Top Fecal Microbiota Transplantation Companies by Revenue (US$ Million) in 2021
Table 20. Global 5 Largest Players Market Share by Fecal Microbiota Transplantation Revenue (CR5 and HHI) & (2017-2022)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Fecal Microbiota Transplantation Product Solution and Service
Table 23. Date of Enter into Fecal Microbiota Transplantation Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Fecal Microbiota Transplantation Market Size by Type (2017-2022) & (US$ Million)
Table 26. Global Fecal Microbiota Transplantation Revenue Market Share by Type (2017-2022)
Table 27. Global Fecal Microbiota Transplantation Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 28. Global Fecal Microbiota Transplantation Revenue Market Share by Type (2023-2028)
Table 29. Global Fecal Microbiota Transplantation Market Size by Application (2017-2022) & (US$ Million)
Table 30. Global Fecal Microbiota Transplantation Revenue Market Share by Application (2017-2022)
Table 31. Global Fecal Microbiota Transplantation Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 32. Global Fecal Microbiota Transplantation Revenue Market Share by Application (2023-2028)
Table 33. North America Fecal Microbiota Transplantation Market Size by Country (2017-2022) & (US$ Million)
Table 34. North America Fecal Microbiota Transplantation Market Size by Country (2023-2028) & (US$ Million)
Table 35. Europe Fecal Microbiota Transplantation Market Size by Country (2017-2022) & (US$ Million)
Table 36. Europe Fecal Microbiota Transplantation Market Size by Country (2023-2028) & (US$ Million)
Table 37. Asia-Pacific Fecal Microbiota Transplantation Market Size by Region (2017-2022) & (US$ Million)
Table 38. Asia-Pacific Fecal Microbiota Transplantation Market Size by Region (2023-2028) & (US$ Million)
Table 39. Latin America Fecal Microbiota Transplantation Market Size by Country (2017-2022) & (US$ Million)
Table 40. Latin America Fecal Microbiota Transplantation Market Size by Country (2023-2028) & (US$ Million)
Table 41. Middle East & Africa Fecal Microbiota Transplantation Market Size by Country (2017-2022) & (US$ Million)
Table 42. Middle East & Africa Fecal Microbiota Transplantation Market Size by Country (2023-2028) & (US$ Million)
Table 43. Rebiotix Company Detail
Table 44. Rebiotix Business Overview
Table 45. Rebiotix Fecal Microbiota Transplantation Product
Table 46. Rebiotix Revenue in Fecal Microbiota Transplantation Business (2017-2022) & (US$ Million)
Table 47. Rebiotix Recent Development
Table 48. Finch Therapeutics Company Detail
Table 49. Finch Therapeutics Business Overview
Table 50. Finch Therapeutics Fecal Microbiota Transplantation Product
Table 51. Finch Therapeutics Revenue in Fecal Microbiota Transplantation Business (2017-2022) & (US$ Million)
Table 52. Finch Therapeutics Recent Development
Table 53. Seres Therapeutics Company Detail
Table 54. Seres Therapeutics Business Overview
Table 55. Seres Therapeutics Fecal Microbiota Transplantation Product
Table 56. Seres Therapeutics Revenue in Fecal Microbiota Transplantation Business (2017-2022) & (US$ Million)
Table 57. Seres Therapeutics Recent Development
Table 58. Crestovo Company Detail
Table 59. Crestovo Business Overview
Table 60. Crestovo Fecal Microbiota Transplantation Product
Table 61. Crestovo Revenue in Fecal Microbiota Transplantation Business (2017-2022) & (US$ Million)
Table 62. Crestovo Recent Development
Table 63. Research Programs/Design for This Report
Table 64. Key Data Information from Secondary Sources
Table 65. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Fecal Microbiota Transplantation Market Share by Type: 2021 VS 2028
Figure 2. Phase-I Features
Figure 3. Phase-2 Features
Figure 4. Phase-3 Features
Figure 5. Phase-4 Features
Figure 6. Global Fecal Microbiota Transplantation Market Share by Application in 2021 & 2028
Figure 7. Clostridium Difficile Infections Case Studies
Figure 8. Parkinson Disease Case Studies
Figure 9. Obesity Case Studies
Figure 10. Diabetes Mellitus Case Studies
Figure 11. Autism Case Studies
Figure 12. Others Case Studies
Figure 13. Fecal Microbiota Transplantation Report Years Considered
Figure 14. Global Fecal Microbiota Transplantation Market Size (US$ Million), Year-over-Year: 2017-2028
Figure 15. Global Fecal Microbiota Transplantation Market Size, (US$ Million), 2017 VS 2021 VS 2028
Figure 16. Global Fecal Microbiota Transplantation Market Share by Region: 2021 VS 2028
Figure 17. Global Fecal Microbiota Transplantation Market Share by Players in 2021
Figure 18. Global Top Fecal Microbiota Transplantation Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Fecal Microbiota Transplantation as of 2021)
Figure 19. The Top 10 and 5 Players Market Share by Fecal Microbiota Transplantation Revenue in 2021
Figure 20. North America Fecal Microbiota Transplantation Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 21. North America Fecal Microbiota Transplantation Market Share by Country (2017-2028)
Figure 22. United States Fecal Microbiota Transplantation Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 23. Canada Fecal Microbiota Transplantation Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 24. Europe Fecal Microbiota Transplantation Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 25. Europe Fecal Microbiota Transplantation Market Share by Country (2017-2028)
Figure 26. Germany Fecal Microbiota Transplantation Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 27. France Fecal Microbiota Transplantation Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 28. U.K. Fecal Microbiota Transplantation Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 29. Italy Fecal Microbiota Transplantation Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 30. Russia Fecal Microbiota Transplantation Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 31. Nordic Countries Fecal Microbiota Transplantation Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 32. Asia-Pacific Fecal Microbiota Transplantation Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 33. Asia-Pacific Fecal Microbiota Transplantation Market Share by Region (2017-2028)
Figure 34. China Fecal Microbiota Transplantation Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 35. Japan Fecal Microbiota Transplantation Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 36. South Korea Fecal Microbiota Transplantation Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 37. Southeast Asia Fecal Microbiota Transplantation Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 38. India Fecal Microbiota Transplantation Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 39. Australia Fecal Microbiota Transplantation Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 40. Latin America Fecal Microbiota Transplantation Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 41. Latin America Fecal Microbiota Transplantation Market Share by Country (2017-2028)
Figure 42. Mexico Fecal Microbiota Transplantation Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 43. Brazil Fecal Microbiota Transplantation Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 44. Middle East & Africa Fecal Microbiota Transplantation Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 45. Middle East & Africa Fecal Microbiota Transplantation Market Share by Country (2017-2028)
Figure 46. Turkey Fecal Microbiota Transplantation Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 47. Saudi Arabia Fecal Microbiota Transplantation Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 48. Rebiotix Revenue Growth Rate in Fecal Microbiota Transplantation Business (2017-2022)
Figure 49. Finch Therapeutics Revenue Growth Rate in Fecal Microbiota Transplantation Business (2017-2022)
Figure 50. Seres Therapeutics Revenue Growth Rate in Fecal Microbiota Transplantation Business (2017-2022)
Figure 51. Crestovo Revenue Growth Rate in Fecal Microbiota Transplantation Business (2017-2022)
Figure 52. Bottom-up and Top-down Approaches for This Report
Figure 53. Data Triangulation
Figure 54. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
